Search Results - "Kleisbauer, J. P."

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer by VON PAWEL, J, SCHILLER, J. H, CARMICHAEL, J, KREBS, J. B, ROSS, G, LANE, S. R, GRALLA, R, SHEPHERD, F. A, FIELDS, S. Z, KLEISBAUER, J. P, CHRYSSON, N. G, STEWART, D. J, CLARK, P. I, PALMER, M. C, DEPIERRE, A

“…Topotecan and cyclophosphamide, doxorubicin, and vincristine (CAV) were evaluated in a randomized, multicenter study of patients with small-cell lung cancer…”
Get full text

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy by Barlési, F, Tchouhadjian, C, Doddoli, C, Torre, J-P, Astoul, P, Kleisbauer, J-P

“…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) as gefitinib emerged as an accepted treatment in second- or third-line setting in…”
Get full text

Randomized multicentric phase II study of carboplatin /gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie) by THOMAS, P, ROBINET, G, KLEISBAUER, J. P, GOUVA, S, FOURNEL, P, LENA, H, LE CAER, H, PEROL, M, BERARD, H, BOMBARON, P, VERGNENEGRE, A

“…To evaluate the efficacy and safety of gemcitabine and carboplatin in the treatment of previously untreated patients with advanced non-small cell lung cancer…”
Get full text

Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study by Goedhals, L., Heron, J.-F., Kleisbauer, J.-P., Pagani, O., Sessa, C.

“…Background The efficacies of granisetron plus dexamethasone and dexamethasone alone in controlling delayed nausea and vomiting after cisplatin chemotherapy…”
Get full text

Phase II Trial of Paclitaxel and Carboplatin in Metastatic Small-Cell Lung Cancer: A Groupe Français de Pneumo-Cancérologie Study by THOMAS, Y. P, CASTELNAU, O, PERDU, D, POIRIER, R, POMMIER DE SANTI, P, PENOT-RAGON, C, KLEISBAUER, J. P, PAILLOTIN, D, LENA, H, ROBINET, G, MUIR, J. F, DELAVAL, P, GOUVA, S, BALMES, P, BLANCHON, F

“…To evaluate the efficacy and safety of paclitaxel and carboplatin in the treatment of previously untreated patients with metastatic small-cell lung cancer…”
Get full text

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer : A phase II trial conducted by the Groupe Français de Pneumo-Cancérologie (GFPC) by VERGNENEGRE, A, DANIEL, C, PREUX, P. M, ROBINET, G, LENA, H, FOURNEL, P, KLEISBAUER, J. P, LE CAER, H, LETREUT, J, PAILLOTIN, D, PEROL, M, BOUCHAERT, E

“…The most satisfactory treatment for patients with locally advanced non-small-cell lung cancer (NSCLC) is combination chemotherapy-radiotherapy (CT-RT). The…”
Get full text

Lenograstim as support for ACE chemotherapy of small-cell lung cancer: A phase III, multicenter, randomized study by GATZEMEIER, U, KLEISBAUER, J. P, PALISSES, R, DRINGS, P, KAUKEL, E, SAMARAS, N, MELO, M. J, CARDENAL, F, ROBINET, G, SNIJDER, R. J, VON PAWEL, J

“…This phase III study was conducted to evaluate the usefulness of lenograstim as support for ACE (doxorubicin, cyclophosphamide, and etoposide) chemotherapy in…”
Get full text

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study by Thomas, Pascal, Robinet, G., Ferri-Dessens, R.M., Léna, H., Gouva, S., Vernejoux, J.M., Kleisbauer, J.P.

“…Background: The purpose of this study was to determine the maximum-tolerated dose (MTD) and the dose-limiting toxicity (DLT) of the 21 days carboplatin plus…”
Get full text

Atopy and systemic reactions to drugs by Haddi, E, Charpin, D, Tafforeau, M, Kulling, G, Lanteaume, A, Kleisbauer, J P, Vervloet, D

“…To elucidate whether systemic reactions (SR) to drugs should be included in the atopic status in epidemiological studies, we compared the distribution of atopy…”
Get more information

Asthma and allergy to house-dust mites in populations living in high altitudes by Charpin, D, Kleisbauer, J P, Lanteaume, A, Razzouk, H, Vervloet, D, Toumi, M, Faraj, F, Charpin, J

“…Do subjects living in high altitude where house-dust mites are known to be uncommon exhibit a lower prevalence of asthma and allergy to house-dust mites? To…”
Get more information

Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome by HERMITTE, L, MARTIN-MOUTOT, N, BOUCRAUT, J, BARONE, R, ATLAN-GEPNER, C, SEAGAR, M, POUGET, J, KLEISBAUER, J.-P, COURAUD, F, VIALETTES, B

“…Some beta-cell-specific autoantigens also are present in the central nervous system. Furthermore, stiff man syndrome, an autoimmune neurological disease, is…”
Get full text

Granisetron plus methylprednisolone for the control of high-dose cisplatin-induced emesis by Kleisbauer, J P, García-Girón, C, Antimi, M, Azevedo, M C, Balmes, H, Massuti-Sureda, B, Contu, A, Luque, A, Pellier, P

“…This double-blind, double-dummy, randomized study compared the 24 h efficacy and safety of granisetron alone (3 mg i.v. over 30 s) or in combination with…”
Get more information

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study by Jacoulet, P., Depierre, A., Moro, D., Rivière, A., Milleron, B., Quoix, E., Ranfaing, E., Anthoine, D., Lafitte, J. J., Lebeau, B., Kleisbauer, J. P., Massin, F., Fournel, P., Zaegel, M., Leclerc, J. P., Garnier, G., Brambilla, E., Capron, F.

“…Background The aim of this study was to analyze SCLC patients beyond 30 months, particularly their outcome, their way of life, and factors which could…”
Get full text

Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring by Hamzaoui, A., Thomas, P., Castelnau, O., Roux, N., Roux, F., Kleisbauer, J.P.

“…To investigate the usefulness of Cyfra 21-1 as an indicator of therapy effectiveness and prognosis in advanced primary lung cancer, sixty-three patients were…”
Get full text

High dose etoposide for brain metastases of small cell lung cancer. A phase II study by POSTMUS, P. E, HAAXMA-REICHE, H, SLEIJFER, D. T, KIRKPATRICK, A, MCVIE, J. G, KLEISBAUER, J. P

“…Symptomatic brain metastases are found in about 40% of patients with small cell lung cancer. Cranial irradiation is the first line treatment for this form of…”
Get full text

Dose optimization of gallium chloride, orally administered, in combination with platinum compounds by Collery, P, Millart, H, Kleisbauer, J P, Paillotin, D, Robinet, G, Durand, A, Claeyssens, S, Legendre, J M, Leroy, A, Rousseau, A

“…An individual dose adaptation for cisplatin (CDDP), etoposide and gallium chloride (GaCl3) was proposed to improve the efficacy of this combination…”
Get more information

Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction by Thomas, P, De Lamballerie, X, Garbe, L, Douagui, H, Kleisbauer, J P

“…Human papillomaviruses (HPV) have been implicated in the pathogenesis of human squamous cell carcinoma, especially of cervical carcinomas. In two previous…”
Get more information

Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer by Pérol, M., Guérin, J.C., Thomas, P., Poirier, R., Carles, P., Robinet, G., Kleisbauer, J.P., Paillotin, D., Vergnenègre, A., Balmes, P., Touron, D., Grivaux, M., Pham, E.

“…The study was designed to evaluate the value of vinorelbine in a cisplatin-mitomycin-vinca alkaloid regimen for treatment of locally advanced or metastatic…”
Get full text

Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study by Steward, W P, Dunlop, D J, Cameron, C, Talbot, D C, Kleisbauer, J P, Thomas, P, Guerin, J C, Perol, M, Sanson, C, Dabouis, G

“…Collaborative phase I and II studies of the combination of gemcitabine and cisplatin in patients with advanced non-small cell lung cancer are ongoing at five…”
Get more information

Sex-difference in reporting allergic symptoms by Charpin, D, Vervloet, D, Razzouk, H, Kleisbauer, J P, Lanteaume, A

Get more information